In contrast, mitral septal E/e' ratio exhibited a trend toward improvement but did not reach statistical significance even in patients treated for ≥4 months, suggesting a more gradual response.
← all excerpts
Real-World Experience of Mavacamten for Patients With Obstructive Hypertrophic Cardiomyopathy in South Korea: A Prospective Multi-Center Observational Study.
1
—
—